WuXi XDC Cayman, Inc. is an investment holding company, which engages in research, discovery, development, and manufacturing of the drug substances and drug products of antibody drug conjugates and other bio conjugates. The company was founded on December 14, 2020 and is headquartered in Wuxi City, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company